This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Companion Animal Specialty Drugs Market

Market Insights on Companion Animal Specialty Drugs covering sales outlook, demand forecast & up-to-date key trends

Companion Animal Specialty Drugs Market By Product (Antibiotics, Anti-Inflammatory Drugs, Parasiticides, Heartworm, Behavioral Products), Distribution Channel (Modern Trade, Online Distribution, Neighborhood Stores, Other Retail Format) & Region - Forecast 2021 - 2031

Companion Animal Specialty Drugs Market Snapshot

As per the Future Market Insights’ (FMI) study, companion animal specialty drugs sales will increase at 4.21% CAGR between 2021 and 2031. The overall market value is projected to reach US$ 36,104.66 Mn in 2021.

With growing popularity of veterinary science as a profession and increasing adoption of companion animals across the U.S., India, the U.K., and Germany, demand for companion animal specialty drugs will rise.

As per FMI’s analysis, Zoetis Inc., Merck and Co., Inc., Bayer AG, Eli Lily and Co. (Elanco), Merial (Sanofi), Ceva Santé Animale, Virbac Animal Health, and Boehringer Ingelheim GmbH are the top players in the market. These companies are expected to account for over 85% of market share in 2021.

Customize this Report

Let us know your requirement to get
100% FREE customization

Key Points Covered in Companion Animal Specialty Drugs Market Study

  • Market estimates and forecast 2021-2031
  • Key drivers and restraints impacting market growth
  • Segment-wise, Country-wise, and Region-wise Analysis
  • Competition Mapping and Benchmarking
  • Brand share and Market Share Analysis
  • Key Product Innovations and Regulatory Climate
  • COVID-19 Impact on Companion Animal Specialty Drugs Market and How to Navigate
  • Recommendation on Key Winning Strategies

How is Future Projection of Companion Animal Specialty Drugs Market Outpacing Historical Sales?

Demand for companion animal specialty drugs increased at a steady pace in the last five years. As per FMI, the market exhibited growth at 5.43% CAGR between 2016 and 2020. Increasing urbanization and adoption of companion animals across the globe will facilitate growth in the market through the assessment period.

The market is slated to gain from the advent of novel technologies and increased research & development activities aimed at developing advanced vaccines, nutritional products, and anti-obesity drugs have spurred the demand.

Companion Animal Specialty Drugs Market Download Report Brochure

Development of recombinant DNA vaccines for dogs is expected to drive the demand for companion animal specialty drugs over the coming years. Due to the rise in vector-borne diseases, adoption of parasiticides has increased, which has improved the market demand.

Increasing prevalence of obesity among pet dogs, especially across the U.K. and Germany have increased the demand for anti-obesity drugs. This has encouraged market players to introduce novel drugs to curb spread of diseases and obesity rate among companion animals.

Spurred by this, the market registered steady year-on-year growth at 5.42% CAGR during 2020-21. Increasing adoption of dogs across the developed nations, including the U.S., Germany and the U.K. will increase the adoption of nutritional products and behavioral products among the pet owners.

Rising Geriatric Population Driving Companion Animal Specialty Drugs Market

Adoption of pets among elderly population has been driving demand for companion animal specialty drugs services. Baby boomers have been increasingly adopting cats and dogs as pets, especially across the U.S. and the U.K.

A clean and hygienic atmosphere at home is essential and preferred by older people. This has led to increased adoption of prophylactic medications for pets and the trend is expected to continue in the upcoming years.

There were more than 3.7 Mn pet owners among the baby boomer generation in the U.S. in 2019, as per American Society for the Prevention of Cruelty to Animals. Pet adoption has been increasing mostly for dogs while feline pet ownership rates have remained stagnant globally over the past five years.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Approval of New Drugs Bolstering Growth

Development and approval of new drugs for the treatment of animal diseases is expected to increase the growth of overall market.

For example - In May 2016, the company announced the approval from the European Medicines Agency (EMA) for Bravecto Spot-On Solution for cats and dogs, and in July 2016, the company received approval in the U.S. to market the product under the trade name Bravecto Topical.

Also, in June 2020, Merck announced the investment of US$ 20 Mn for the facility expansion and improvement in its manufacturing site established in the U.S. in De Soto, Kansas. The site produces vaccines and the investment was for the improvement of its production capabilities to cater the demand for compounded vaccines.

Country-wise Insights

How is the Companion Animal Specialty Drugs Market Expanding in the U.S.?

The companion animal specialty drugs market is poised to accrue significant gains across the U.S. Rising adoption of pet across the country have improved the sales of companion animal specialty drugs.

According to the survey of American Society for the Prevention of Cruelty to Animals, nearly 6.5 million companion animals enter the U.S. animal shelters every year. Among these, 3.3 million are dogs and 3.2 million are cats. Approximately, 3.2 million shelter animals are adopted every year.

It is estimated that around 44% of households in the U.S. have a dog and nearly 33% have a cat. With growing adoption of companion animals in the U.S., pet owners are increasing their awareness about the maintenance of their pet. Now, internet being the primary source and with rising penetration of social media, millennials and baby boomers are taking extra-care for their pet wellbeing.

This includes proper vaccination for their pet, which is directly impacting the companion animal specialty drugs market positively. Apart from this, rising cases of vector borne diseases among the companion animals will fuel demand in the U.S. market.

How will Demand for Companion Animal Specialty Drugs Fare in the U.K.?

The U.K. is anticipated to be the most lucrative market across Europe for companion animal specialty drugs. Growth registered in the U.K. can be attributed to the growing adoption of companion animals across the country.

Obesity in pets is another major factor driving the companion animal specialty drugs market. A study by Royal Veterinary College has revealed that 1 in 14 dogs in the U.K. are recorded by their vets as overweight.

Pet Food Manufacture Association stated in its White Paper-2019 survey that, 74% of veterinary professionals believe that prevalence of obesity has increased over the past 5 years. To reduce the statistics, many private and public organizations are encouraging the use of anti-obesity drugs and nutritional products, propelling the demand for companion animal specialty drugs market across the U.K.

How is Germany’s Companion Animal Specialty Drugs Market Expected to Perform?

With initiatives undertaken to lower the obesity rate among companion animals and rapid adoption of nutritional and anti-obesity drugs, the Germany’s companion animal specialty drugs market is expected to witness significant growth during the assessment period.

Alongside this, adoption of pets across Germany have increased the growth prospects for the market players. Unprecedented outbreak of coronavirus compelled people around the world to spend more time indoors, resulting in increased adoption of dogs.

Global shutdown caused a spike in demand for companion animals, especially puppies in Germany. According to the German Canine Association (VDH), demand for dogs across Germany increased by 20% in FQ-20.

With rising adoption, demand for nutritional products, anti-inflammatory medicines, and other drugs for pets burgeoned.

What are the Key Factors Enabling Growth in India?

India is expected to dominate the South Asia’s companion animal specialty drugs market during the forecast period. Demand for vaccines, nutritional products, behavioral drugs, and specialty drugs will increase due to the rising adoption of companion animals.

Growing urbanization, technological advancements, and awareness regarding animal cruelty have significantly improved the adoption of companion animals across India. Penetration of social media and campaigns implemented to increase the awareness about the cruelty against animals and pet adoption have impacted the market positively.

As per National Geographic statistics, India is home to around 35 million street dogs and the number is likely to increase by 2030. Recently, due to Covid-19 adoption of dogs have significantly increased in India, says Humanities and Social Sciences Communications. This has in turn resulted in higher focus on the treatment of companion animals for various diseases, which will bode well for the market in India.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Category-wise Insights

Which is the Top-selling Companion Animal Specialty Drug?

FMI estimates, parasiticides segment is expected to account for over 32% of revenue share in the global companion animal specialty drugs market. Increasing adoption for treatment of various animal diseases have prompted the growth of this segment.

Veterinary parasiticides or antiparasitics are the products that treat vector-borne diseases and kill parasites that infect pets, livestock, and other animals. Rising prevalence of vector-borne diseases among pets, especially dogs, have increased the adoption of parasiticides within veterinary clinics and hospitals.

What is the Scope of Sales through Veterinary Clinics?

Demand for companion animal specialty drugs for the veterinary clinics distribution channel is anticipated to be relatively strong, owing to the increasing pet adoption and rising awareness among the people regarding animal diseases.

As per Future Market Insights, the veterinary clinics segment is anticipated to contribute over 52% of value share in global companion animal specialty drugs market during the forecast period.

Competitive Landscape

Future Market Insights forecasts, increasing strategic acquisition and collaboration activities among the companies has led to intense consolidation. Key players are also focusing on research and development activities to develop more effective drugs for the treatment of cats and dogs.

For instance, Aeronics Inc., a Pittsburgh-based startup that develops innovative oxygen technologies for veterinary use announced the collaboration with MWI Animal Health, a leading distributor of animal health products to expedite veterinarians access to portable oxygen.

Also, in January 2021, Merck Animal Health, known as MSD Animal Health outside the U.S. and Canada, a division of Merck & Co. Inc., announced the collaboration with the Street Dog Coalition to offer medications, vaccines, treatment for pets of those experiencing homelessness.

In June 2021, ALR Technologies SG Pvt. Ltd., the diabetes management company announced the establishment of its new business division which will be the world’s first and only CGM for diabetic companion animals, known as, ‘ALRT Animal Health Division’.

*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report.

Scope of Report

Attribute

Details

Forecast Period

2021-2031

Historical Data Available for

2016-2020

Market Analysis

USD Million for Value

Key Regions Covered

North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa

Key Countries Covered

US, Canada, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, and South Africa

Key Segments Covered

Distribution Channel, Product, and Region

Key Companies Profiled

  • Zoetis Inc.
  • Merck & Co. Inc.
  • Bayer AG
  • Eli Lily & Co.
  • Boehringer Ingelheim GmbH
  • Others

Report Coverage

Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Companion Animal Specialty Drugs Market by Category

By Product:

  • Antibiotics
  • Anti-Inflammatory Drugs
  • Parasiticides
  • Heartworm
  • Behavioral Products
  • Nutritional Products
  • Anti-Obesity Drugs
  • Skin Care Products
  • Vaccines

By Distribution Channel:

  • Modern Trade
  • Online Distribution
  • Neighborhood Stores
  • Other Retail Format

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa (MEA)

Frequently Asked Questions

The companion animal specialty drugs market is expected to exceed US$36,104.66 Mn in 2021

The companion animal specialty drugs market projected steady growth, registering a CAGR at 5.43% between 2016 and 2020.

Growing demand for compounded medications and increasing adoption of anti-obesity drugs to reduce the growing obesity rate among pets will drive the sales.

Zoetis Inc., Merck and Co., Inc., Bayer AG, Eli Lily and Co. (Elanco), Merial (Sanofi), Ceva Santé Animale, Virbac Animal Health, and Boehringer Ingelheim GmbH, are the top players FMI identifies as key players.

North America’s companion animal specialty drugs market demand is set to rise at over 3.38% CAGR during the forecast period of 2021 and 2031.

The top 10 players in the companion animal specialty drugs market will collectively account for over 85% of global market share in the year 2021.

Demand for companion animal specialty drugs across Europe will exhibit steady expansion at 5.28% during the forecast period of 2021 and 2031.

Top countries in terms of companion animal specialty drugs distribution are China, the U.K., the U.S., India and Germany.

In 2021, Japan accounted for 6.4% market share while South Korea contributed less than 1% market share.

Table of Content

1. Executive Summary

2. Market Introduction

   2.1. Market Definition

   2.2. Market Taxonomy

3. Global Companion Animal Drugs Market Analysis Scenario

   3.2. Market Size (US$ Mn) and Forecast

       3.2.1. Market Size and Y-o-Y Growth

4. Market Dynamics

   4.1. Drivers

   4.2. Restraints

   4.3. Opportunity

   4.4. Global Trends

   4.5. PEST Analysis - U.S.

   4.6. PEST Analysis - Europe

   4.7. Portor's Five Analysis

   4.8. Trilateral regulatory harmonization between U.S., EU and Japan on registration of veterinary products

5. Global Companion Animal Drugs Market Analysis and Forecasts, By Product Type 

   5.1. Introduction

   5.2. Basis Point Share (BPS) Analysis By Product Type

   5.3. Y-o-Y Growth Projections By Product Type

   5.4. Market Value Forecast By Product Type, 2021–2031

       5.4.1. Antibiotics

       5.4.2. Anti-inflammatory Drugs

       5.4.3. Parasiticides

       5.4.4. Heartworm

       5.4.5. Behavioral Products

       5.4.6. Nutritional Products

       5.4.7. Anti-Obesity Drugs

       5.4.8. Skin Care Products

       5.4.9. Vaccines

   5.5. Market Attractiveness By Product Type 

6. Global Companion Animal Drugs Market Analysis and Forecasts, By Distribution Channel 

   6.1. Introduction

   6.2. Basis Point Share (BPS) Analysis By Distribution Channel 

   6.3. Y-o-Y Growth Projections By Distribution Channel 

   6.4. Market Value Forecast By Distribution Channel, 2021–2031

       6.4.1. Veterinary Hospitals

       6.4.2. Veterinary Clinics

       6.4.3. Pharmacies and Drug Stores

   6.5. Market Attractiveness By Distribution Channel 

7. Global Companion Animal Drugs Market Analysis and Forecasts, By Region

   7.1. Basis Point Share (BPS) Analysis By Region

   7.2. Y-o-Y Growth Projections By Region

   7.3. Market Value Forecast By Region

       7.3.1. North America 

       7.3.2. Latin America 

       7.3.3. Western Europe 

       7.3.4. Eastern Europe 

       7.3.5. APEJ 

       7.3.6. Japan 

       7.3.7. MEA 

   7.4. Market Attractiveness By Region

8. North America Companion Animal Drugs Market Analysis and Forecast

   8.1. Introduction

       8.1.1. Basis Point Share (BPS) Analysis By Country

       8.1.2. Y-o-Y Growth Projections By Country

   8.2. Market Value Forecast By Product Type, 2021–2031

       8.2.1. Antibiotics

       8.2.2. Anti-inflammatory Drugs

       8.2.3. Parasiticides

       8.2.4. Heartworm

       8.2.5. Behavioral Products

       8.2.6. Nutritional Products

       8.2.7. Anti-Obesity Drugs

       8.2.8. Skin Care Products

       8.2.9. Vaccines

   8.3. Market Value Forecast By Distribution Channel, 2021–2031

       8.3.1. Veterinary Hospitals

       8.3.2. Veterinary Clinics

       8.3.3. Pharmacies and Drug Stores

   8.4. Market Value Forecast By Country, 2021–2031

       8.4.1. U.S.

       8.4.2. Canada

   8.5. Market Attractiveness Analysis 

       8.5.1. By Product Type 

       8.5.2. By Distribution Channel 

       8.5.3. By Country

   8.6. Regional Trends 

   8.7. Drivers and Restraints: Impact Analysis 

9. Latin America Companion Animal Drugs Market Analysis and Forecast

   9.1. Introduction

       9.1.1. Basis Point Share (BPS) Analysis By Country

       9.1.2. Y-o-Y Growth Projections By Country

   9.2. Market Value Forecast By Product Type, 2021–2031

       9.2.1. Antibiotics

       9.2.2. Anti-inflammatory Drugs

       9.2.3. Parasiticides

       9.2.4. Heartworm

       9.2.5. Behavioral Products

       9.2.6. Nutritional Products

       9.2.7. Anti-Obesity Drugs

       9.2.8. Skin Care Products

       9.2.9. Vaccines

   9.3. Market Value Forecast By Distribution Channel, 2021–2031

       9.3.1. Veterinary Hospitals

       9.3.2. Veterinary Clinics

       9.3.3. Pharmacies and Drug Stores

   9.4. Market Value Forecast By Country, 2021–2031

       9.4.1. Brazil

       9.4.2. Mexico

       9.4.3. Argentina

       9.4.4. Rest of Latin America

   9.5. Market Attractiveness Analysis 

       9.5.1. By Product Type 

       9.5.2. By Distribution Channel 

       9.5.3. By Country

   9.6. Regional Trends 

   9.7. Drivers and Restraints: Impact Analysis 

10. Western Europe Companion Animal Drugs Market Analysis and Forecast

   10.1.Introduction

       10.1.1. Basis Point Share (BPS) Analysis By Country

       10.1.2. Y-o-Y Growth Projections By Country

   10.2.Market Value Forecast By Product Type, 2021–2031

       10.2.1. Antibiotics

       10.2.2. Anti-inflammatory Drugs

       10.2.3. Parasiticides

       10.2.4. Heartworm

       10.2.5. Behavioral Products

       10.2.6. Nutritional Products

       10.2.7. Anti-Obesity Drugs

       10.2.8. Skin Care Products

       10.2.9. Vaccines

   10.3.Market Value Forecast By Distribution Channel, 2021–2031

       10.3.1. Veterinary Hospitals

       10.3.2. Veterinary Clinics

       10.3.3. Pharmacies and Drug Stores

   10.4.Market Value Forecast By Country, 2021–2031

       10.4.1. U.K.

       10.4.2. Germany

       10.4.3. France

       10.4.4. Italy

       10.4.5. Spain

       10.4.6. Nordics

       10.4.7. Benelux

       10.4.8. Rest of Western Europe

   10.5.Market Attractiveness Analysis 

       10.5.1. By Product Type 

       10.5.2. By Distribution Channel 

       10.5.3. By Country

   10.6. Regional Trends 

   10.7. Drivers and Restraints: Impact Analysis 

11. Eastern Europe Companion Animal Drugs Market Analysis and Forecast

   11.1.Introduction

       11.1.1. Basis Point Share (BPS) Analysis By Country

       11.1.2. Y-o-Y Growth Projections By Country

   11.2.Market Value Forecast By Product Type, 2021–2031

       11.2.1. Antibiotics

       11.2.2. Anti-inflammatory Drugs

       11.2.3. Parasiticides

       11.2.4. Heartworm

       11.2.5. Behavioral Products

       11.2.6. Nutritional Products

       11.2.7. Anti-Obesity Drugs

       11.2.8. Skin Care Products

       11.2.9. Vaccines

   11.3.Market Value Forecast By Distribution Channel, 2021–2031

       11.3.1. Veterinary Hospitals

       11.3.2. Veterinary Clinics

       11.3.3. Pharmacies and Drug Stores

   11.4.Market Value Forecast By Country, 2021–2031

       11.4.1. Russia

       11.4.2. Poland

       11.4.3. Rest of Eastern Europe

   11.5.Market Attractiveness Analysis 

       11.5.1. By Product Type 

       11.5.2. By Distribution Channel 

       11.5.3. By Country

   11.6. Regional Trends 

   11.7. Drivers and Restraints: Impact Analysis 

12. APEJ Companion Animal Drugs Market Analysis and Forecast

   12.1.Introduction

       12.1.1. Basis Point Share (BPS) Analysis By Country

       12.1.2. Y-o-Y Growth Projections By Country

   12.2.Market Value Forecast By Product Type, 2021–2031

       12.2.1. Antibiotics

       12.2.2. Anti-inflammatory Drugs

       12.2.3. Parasiticides

       12.2.4. Heartworm

       12.2.5. Behavioral Products

       12.2.6. Nutritional Products

       12.2.7. Anti-Obesity Drugs

       12.2.8. Skin Care Products

       12.2.9. Vaccines

   12.3.Market Value Forecast By Distribution Channel, 2021–2031

       12.3.1. Veterinary Hospitals

       12.3.2. Veterinary Clinics

       12.3.3. Pharmacies and Drug Stores

   12.4.Market Value Forecast By Country, 2021–2031

       12.4.1. China

       12.4.2. India

       12.4.3. Australia & New Zealand

       12.4.4. ASEAN

       12.4.5. Rest of APEJ

   12.5.Market Attractiveness Analysis 

       12.5.1. By Product Type 

       12.5.2. By Distribution Channel 

       12.5.3. By Country

   12.6. Regional Trends 

   12.7. Drivers and Restraints: Impact Analysis 

13. Japan Companion Animal Drugs Market Analysis and Forecast

   13.1.Introduction

       13.1.1. Absolute $ Opportunity (US$ Mn), 2021–2031

   13.2.Market Value Forecast By Product Type, 2021–2031

       13.2.1. Antibiotics

       13.2.2. Anti-inflammatory Drugs

       13.2.3. Parasiticides

       13.2.4. Heartworm

       13.2.5. Behavioral Products

       13.2.6. Nutritional Products

       13.2.7. Anti-Obesity Drugs

       13.2.8. Skin Care Products

       13.2.9. Vaccines

   13.3.Market Value Forecast By Distribution Channel, 2021–2031

       13.3.1. Veterinary Hospitals

       13.3.2. Veterinary Clinics

       13.3.3. Pharmacies and Drug Stores

   13.4.Market Attractiveness Analysis 

       13.4.1. By Product Type 

       13.4.2. By Distribution Channel 

   13.5. Regional Trends 

   13.6. Drivers and Restraints: Impact Analysis 

14. MEA Companion Animal Drugs Market Analysis and Forecast

   14.1.Introduction

       14.1.1. Basis Point Share (BPS) Analysis By Country

       14.1.2. Y-o-Y Growth Projections By Country

   14.2.Market Value Forecast By Product Type, 2021–2031

       14.2.1. Antibiotics

       14.2.2. Anti-inflammatory Drugs

       14.2.3. Parasiticides

       14.2.4. Heartworm

       14.2.5. Behavioral Products

       14.2.6. Nutritional Products

       14.2.7. Anti-Obesity Drugs

       14.2.8. Skin Care Products

       14.2.9. Vaccines

   14.3.Market Value Forecast By Distribution Channel, 2021–2031

       14.3.1. Veterinary Hospitals

       14.3.2. Veterinary Clinics

       14.3.3. Pharmacies and Drug Stores

   14.4.Market Value Forecast By Country, 2021–2031

       14.4.1. GCC Countries

       14.4.2. South Africa

       14.4.3. Rest of MEA

   14.5.Market Attractiveness Analysis 

       14.5.1. By Product Type 

       14.5.2. By Distribution Channel 

       14.5.3. By Country

   14.6. Regional Trends 

   14.7. Drivers and Restraints: Impact Analysis 

15. Competition Landscape

   15.1. Competition Dashboard

   15.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments and SWOT Analysis)

       15.2.1. Zoetis, Inc.

       15.2.2. Merck and Co., Inc.

       15.2.3. Bayer AG 

       15.2.4. Elanco

       15.2.5. Boehringer Ingelheim Animal Health

       15.2.6. Ceva Santé Animale 

16. Assumptions and Acronyms Used

17. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product Type, 2021 - 2031

Table 02: Global Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2021 - 2031

Table 03: Global Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Region, 2021 - 2031

Table 04: North America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2021 - 2031

Table 05: North America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2021 - 2031

Table 06: North America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2021 - 2031

Table 07: Latin America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2021 - 2031

Table 08: Latin America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2021 - 2031

Table 09: Latin America Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2021 - 2031

Table 10: Western Europe Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2021 - 2031

Table 11: Global Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2021 - 2031

Table 12: Global Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2021 - 2031

Table 13: Eastern Europe Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2021 - 2031

Table 14: Eastern Europe Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2021 - 2031

Table 15: Eastern Europe Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2021 - 2031

Table 16: APEJ Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2021 - 2031

Table 17: APEJ Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2021 - 2031

Table 18: APEJ Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2021 - 2031

Table 19 : Japan Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast, 2021 - 2031

Table 20: Japan Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2021 - 2031

Table 21: Japan Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2021 - 2031

Table 22: MEA Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Country, 2021 - 2031

Table 23: MEA Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Product, 2021 - 2031

Table 24: MEA Companion Animal Specialty Drugs Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2021 - 2031

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Companion Animal Drugs Market Size (US$ Mn) By Product Type, 2021 & 2031

Figure 02: Global Companion Animal Drugs Market Share Analysis (%) By Product Type, 2021 & 2031

Figure 03: Global Companion Animal Drugs Market Y-o-Y Growth (%) By Product Type, 2021 - 2031 

Figure 04: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Antibiotics Segment, 2021 - 2031

Figure 05: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Anti-inflammatory Drugs Segment, 2021 - 2031

Figure 06: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Parasiticides Segment, 2021 - 2031

Figure 07: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Heartworm Segment, 2021 - 2031

Figure 08: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Behavioral Products Segment, 2021 - 2031

Figure 09: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) Nutritional Products Segment, 2021 - 2031

Figure 10: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Anti-Obesity Drugs Segment, 2021 - 2031

Figure 11: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Skin Care Products Segment, 2021 - 2031

Figure 12: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Vaccines Segment, 2021 - 2031

Figure 13: Global Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2021 - 2031 

Figure 14 : Global Companion Animal Drugs Market Size (US$ Mn) By Distribution Channel, 2021 & 2031

Figure 15: Global Companion Animal Drugs Market Share by Distribution Channel, 2021 - 2031

Figure 16: Global Companion Animal Drugs Market Y-o-Y Growth (%) By Distribution Channel, 2021 - 2031 

Figure 17: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Veterinary Hospitals Segment, 2021 - 2031

Figure 18: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Veterinary Clinics Segment, 2021 - 2031

Figure 19: Global Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn) By Pharmacies and Drug Stores Segment, 2021 - 2031

Figure 20: Global Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2021 - 2031 

Figure 21: Global Companion Animal Drugs Market Size (US$ Mn) By Region, 2021 & 2031

Figure 22: Global Companion Animal Drugs Market Share Analysis (%) By Region, 2021 & 2031

Figure 23: Global Companion Animal Drugs Market Y-o-Y Growth (%) By Region, 2021 - 2031 

Figure 24: North America Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 25: Latin America Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 26: Western Europe Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 27: Eastern Europe Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 28: APEJ Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 29: Japan Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 30: MEA Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 31: Global Companion Animal Drugs Market Attractiveness Analysis By Region, 2021 - 2031 

Figure 32: North America Companion Animal Drugs Market Share Analysis (%) By Country, 2017 - 2027

Figure 33: North America Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2021 - 2031 

Figure 34: The U.S. Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn),

Figure 35: Canada Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn),

Figure 36: North America Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2021 - 2031

Figure 37: North America Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2021 - 2031 

Figure 38: Global Companion Animal Drugs Market Attractiveness Analysis By Country, 2021 - 2031 

Figure 39: Latin America Companion Animal Drugs Market Share Analysis (%) By Country, 2021 - 2031

Figure 40: Latin America Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2021 - 2031 

Figure 41: Brazil Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 42: Mexico Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 43: Argentina Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 44: Rest of Latin America Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 45: Latin America Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2021 - 2031

Figure 46: Latin America Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2021 - 2031 

Figure 47: Latin America Companion Animal Drugs Market Attractiveness Analysis By Country, 2021 - 2031 

Figure 48: Western Europe Companion Animal Drugs Market Share Analysis (%) By Country, 2021 & 2031

Figure 49: Western Europe Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2021 - 2031 

Figure 50: U.K. Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 51: Germany Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 52: France Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn),

Figure 53: Italy Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 54: Spain Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 55: Nordic Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn),

Figure 56:  Benelux Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 57: Rest of Western Europe Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 58: Western Europe Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2021 - 2031

Figure 59: Western Europe Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2021 - 2031 

Figure 60: Western Europe Companion Animal Drugs Market Attractiveness Analysis By Country, 2021 - 2031 

Figure 61: Eastern Europe Companion Animal Drugs Market Share Analysis (%) By Country, 2021 - 2031

Figure 62: Eastern Europe Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2021 - 2031 

Figure 63: Russia Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 64: Poland Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 65: Rest of Eastern Europe Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 66: Eastern Europe Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2021 - 2031

Figure 67: Eastern Europe Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2021 - 2031 

Figure 68: Eastern Europe Companion Animal Drugs Market Attractiveness Analysis By Country, 2021 - 2031 

Figure 69: APEJ Companion Animal Drugs Market Share Analysis (%) By Country, 2017 &  2027

Figure 70: APEJ Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2021 - 2031 

Figure 71: China Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 72: India Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 73: A&NZ Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 74: ASEAN Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 75: Rest of APEJ Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 76: APEJ Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2021 - 2031

Figure 77: APEJ Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2021 - 2031 

Figure 78: APEJ Companion Animal Drugs Market Attractiveness Analysis By Country, 2021 - 2031 

Figure 79: Japan Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 80: Japan Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2021 - 2031

Figure 81: Japan Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2021 - 2031 

Figure 82: MEA Companion Animal Drugs Market Share Analysis (%) By Country, 2021 & 2031

Figure 83: MEA Companion Animal Drugs Market Y-o-Y Growth (%) By Country, 2021 - 2031 

Figure 84: GCC countries Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 85: South Africa Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 86: Rest of MEA Companion Animal Drugs Market Absolute $ Opportunity (US$ Mn), 2021 - 2031

Figure 87: North America Companion Animal Drugs Market Attractiveness Analysis By Product Type, 2021 - 2031

Figure 88: North America Companion Animal Drugs Market Attractiveness Analysis By Distribution Channel, 2021 - 2031 

Figure 89: MEA Companion Animal Drugs Market Attractiveness Analysis By Country, 2021 - 2031 

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Companion Animal Specialty Drugs Market